Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride's potential harms are hard to accurately measure.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Fungal infection was the main cause of hair loss in Egyptian children studied.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

Acne keloidalis nuchae is a tough-to-treat condition that greatly affects quality of life, especially in men of African descent.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Smoking and certain health conditions like thyroid disease may make palmoplantar pustulosis harder to treat.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

Male pattern baldness is a common hair loss in men caused by genetics and hormones, with treatments including drugs, hair transplants, and hair loss products.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Mesenchymal stem cells could help treat radiation-induced bladder damage but more research is needed to overcome current limitations.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Patients with nonmelanoma skin cancers are most bothered by fear of progression, appearance concerns, and having cancer.

JetPeel-assisted minoxidil improves hair density and thickness more than minoxidil alone.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Older men with late-onset lupus have a higher mortality rate than women.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Most women with hair loss using 5% topical Minoxidil are satisfied with the treatment, but hair loss still affects their daily habits and social life.

Endocrine therapies for cancer significantly increase the risk of hair loss.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Taking too many vitamin and mineral supplements can cause serious health problems.

Tamsulosin increases the risk of floppy iris during eye surgery.

Cannabis, cryotherapy, and scalp cooling can help improve the quality of life for chemotherapy patients.